INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·13d ago
More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·20d ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·27d ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·1mo ago
Avista Healthcare Partners Announces Promotions
Avista Healthcare Partners Announces Promotions Avista Healthcare Partners Announces Promotions PR Newswire NEW YORK, Jan. 5, 2026 NEW YORK, Jan. 5, 2026 /PRNewswire/ -- Avista Healthcare Partners...
PR Newswire·1mo ago
Organogenesis (NASDAQ:ORGO) Shares Down 5% - Here's What Happened
Organogenesis (NASDAQ:ORGO) Stock Price Down 5% - What's Next...
MarketBeat·1mo ago
Organogenesis (NASDAQ:ORGO) Shares Gap Down - Time to Sell?
Organogenesis (NASDAQ:ORGO) Shares Gap Down - Should You Sell...
MarketBeat·2mo ago
Assenagon Asset Management S.A. Has $20.49 Million Stock Position in Organogenesis $ORGO
Assenagon Asset Management S.A. lifted its holdings in Organogenesis (NASDAQ:ORGO - Free Report) by 69.9% during the third quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·2mo ago
Organogenesis (NASDAQ:ORGO) Shares Down 3.7% on Insider Selling
Organogenesis (NASDAQ:ORGO) Trading Down 3.7% on Insider Selling...
MarketBeat·2mo ago
Insider Selling: Organogenesis (NASDAQ:ORGO) Director Sells 200,000 Shares of Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Glenn Nussdorf sold 200,000 shares of the business's stock in a transaction on Tuesday, December 16th. The stock was sold at an average price of...